Sort
51,593 grants matching “hepatitis”
Defining the role of antigen-specific T cell responses in NASH
$599,541Matthew A Burchill · University Of Colorado Denver · R56 · FY2024 · DK
Effects of Persistent Innate Immune Activation on Vaccine Efficacy
$599,480Charles M. Rice · Rockefeller University · U19 · FY2017 · AI
Therapeutic vaccine platform to boost immune responses in Tuberculosis
$599,471Karen G. Anthony · L2 Diagnostics, Llc · N43 · FY2025 · AI
GH13-006: RESEARCH AND TECHNICAL ASSISTANCE FO REPUBLIC HEALTH INT
$599,460Luc Moise Wedner Pierre · Moh/Build/Strengthen/Haiti'S Plan/Preven · U01 · FY2016 · GH
The role of endogenous low molecular weight mineralization inhibitors in spine health
$599,407Koen Van De Wetering · Thomas Jefferson University · R01 · FY2025 · AR
Collaborative Integration of HCV Molecular Virology and Mathematical Modeling
$599,360Susan L Uprichard · Loyola University Chicago · R01 · FY2020 · AI
Multiepitope circumsporozoite P.falciparum malaria subunit vaccine displayed on v
$599,338David R. Milich · Vaccine Research Institute Of San Diego · R01 · FY2010 · AI
The role of hexokinase 2 in liver fibrosis and NASH-induced HCC
$599,299Nissim Hay · University Of Illinois At Chicago · R01 · FY2024 · CA
Changes in phosphate metabolism cause pathologic cardiac remodeling in chronic kidney disease (CKD)
$599,299Kenneth E White · Indiana University Indianapolis · R01 · FY2019 · HL
Staying Safe: Long-Term Injection Drug Users Who Have Avoided HIV & Hepatitis C
$599,233Samuel R Friedman · National Development And Research Institutes, Inc. · R01 · FY2008 · DA
Ethanol Effects on the Transcriptional Regulatory Network in Liver Regeneration
$599,223Joannes B Hoek · Thomas Jefferson University · R01 · FY2021 · AA
Small molecule antagonists targeting EphB receptors for the treatment of nonalcoholic steatohepatitis (NASH)
$599,169Patrice Mimche · University Of Utah · R01 · FY2022 · DK
Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism
$599,157Robert Clayton Bauer · Columbia University Health Sciences · R01 · FY2025 · DK
Risk of Influenza Infection In A Vaccinated Obese Population
$599,156Melinda A. Beck · Univ Of North Carolina Chapel Hill · R01 · FY2009 · AI
Effects of Persistent Innate Immune Activation on Vaccine Efficacy
$599,052Charles M. Rice · Rockefeller University · U19 · FY2014 · AI
Characterization Methodologies & Proteomics to Assess Carbon Nanotube Exposure
$599,000Frank A Witzmann · Indiana University Indianapolis · RC2 · FY2010 · ES
Discordant transcriptional regulation of gluconeogenic and lipogenic gene expression
$598,996Jeffrey E Pessin · Albert Einstein College Of Medicine · R01 · FY2025 · DK
Discordant transcriptional regulation of gluconeogenic and lipogenic gene expression
$598,996Jeffrey E Pessin · Albert Einstein College Of Medicine · R01 · FY2021 · DK
Discordant transcriptional regulation of gluconeogenic and lipogenic gene expression
$598,996Jeffrey E Pessin · Albert Einstein College Of Medicine · R01 · FY2022 · DK
Discordant transcriptional regulation of gluconeogenic and lipogenic gene expression
$598,996Jeffrey E Pessin · Albert Einstein College Of Medicine · R01 · FY2023 · DK
Genes and Gene Networks Associated with Obesity and Diabetes
$598,977Alan D Attie · University Of Wisconsin-Madison · R01 · FY2011 · DK
Genes and Gene Networks Associated with Obesity and Diabetes
$598,977Alan D Attie · University Of Wisconsin-Madison · R01 · FY2012 · DK
Cryopreservation and nanowarming enables whole liver banking for transplantation, cell therapy and biomedical research
$598,916Erik Brian Finger · University Of Minnesota · R01 · FY2025 · DK
Randomized Trial of Diet in GDM: Metabolic Consequences to Mother and Offspring
$598,883Teri L Hernandez · University Of Colorado Denver · R01 · FY2017 · DK
Ontogeny of drug transport
$598,784Bhagwat Prasad · Washington State University · R01 · FY2024 · HD